Effective November 26, 2025: Clinical Policies
Date: 11/19/25
Superior HealthPlan has updated certain clinical policies to ensure medical necessity review criteria is current and appropriate for members and the scope of services provided. As a result, the following policies are effective on November 26, 2025, at 12:00AM.
Changes in these policies reflect preauthorization requirement amendments that are less burdensome to insureds, physicians, or health care providers.
Policy | Applicable Products | New Policy Overview or Updated Policy Revisions |
Cranial Remolding Orthosis (TX.CP.MP.523) | Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), and CHIP | New Policy Overview:
|
Electric Tumor Treating Fields (Optune) CP.MP.145 | Ambetter | Policy updates include:
|
Enteral Nutrition and Supplies (TX.CP.MP.550) | Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), and CHIP | Policy updates include:
|
IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (CP.MP.61) | Ambetter | Policy updates include:
|
To review all policies, please visit Superior’s Clinical, Payment & Pharmacy Policies webpage.
Prior to updates, Medical Clinical policies are reviewed and approved by the Utilization Management Committee.
For questions or additional information, contact Superior’s Prior Authorization department at 1-800-218-7508.